• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乳果糖、乳酸菌、肠道微生态与黏膜保护

Lactulose, lactic acid bacteria, intestinal microecology and mucosal protection.

作者信息

Salminen S, Salminen E

机构信息

Dept. of Biochemistry and Food Chemistry, Turku University Hospital, Finland.

出版信息

Scand J Gastroenterol Suppl. 1997;222:45-8. doi: 10.1080/00365521.1997.11720717.

DOI:10.1080/00365521.1997.11720717
PMID:9145446
Abstract

During the fermentation of lactulose, short-chain fatty acids are formed with consequent lowering of the colon pH and modification of the microflora. Lactulose promotes the growth of lactic acid bacteria and bifidobacteria and, more specifically, Lactobacillus acidophilus in the colon. Lactulose and lactulose-containing products fermented with lactic acid bacteria lower colonic pH balancing intestinal microecology and normalizing intestinal transit. In animal studies, lactulose promotes a mainly Gram-positive faecal microflora, but large doses of lactulose may be associated with transient diarrhoea. Our studies indicate that lactulose with lactic acid bacteria effectively relieves constipation in human volunteers. Lactulose with lactic acid bacteria in a fermented diary product can balance and prevent radiotherapy-associated diarrhoea and intestinal side effects. Normalizing the intestinal flora and stabilizing mucosal integrity with lactulose has beneficial effects in intestinal disorders. Lactulose and lactic acid bacteria offer a promising ingredient combination for future functional and special dietary foods in treating intestinal disturbances.

摘要

在乳果糖发酵过程中,会形成短链脂肪酸,从而降低结肠pH值并改变微生物群落。乳果糖促进结肠中乳酸菌和双歧杆菌的生长,更具体地说,促进嗜酸乳杆菌的生长。用乳酸菌发酵的乳果糖和含乳果糖产品可降低结肠pH值,平衡肠道微生态并使肠道转运正常化。在动物研究中,乳果糖促进主要为革兰氏阳性的粪便微生物群落生长,但大剂量乳果糖可能与短暂腹泻有关。我们的研究表明,含乳酸菌的乳果糖可有效缓解人类志愿者的便秘。发酵乳制品中含乳酸菌的乳果糖可平衡并预防放疗相关的腹泻和肠道副作用。用乳果糖使肠道菌群正常化并稳定黏膜完整性对肠道疾病有有益作用。乳果糖和乳酸菌为未来治疗肠道紊乱的功能性和特殊膳食食品提供了一种有前景的成分组合。

相似文献

1
Lactulose, lactic acid bacteria, intestinal microecology and mucosal protection.乳果糖、乳酸菌、肠道微生态与黏膜保护
Scand J Gastroenterol Suppl. 1997;222:45-8. doi: 10.1080/00365521.1997.11720717.
2
Faecal steroids and colorectal cancer: the effect of lactulose on faecal bacterial metabolism in a continuous culture model of the large intestine.粪便类固醇与结直肠癌:在大肠连续培养模型中乳果糖对粪便细菌代谢的影响
Eur J Cancer Prev. 1992 Feb;1(2):113-27.
3
Effect of lactulose on short-chain fatty acids and lactate production and on the growth of faecal flora, with special reference to Clostridium difficile.乳果糖对短链脂肪酸和乳酸生成以及对粪便菌群生长的影响,特别提及艰难梭菌。
J Med Microbiol. 1997 Jan;46(1):80-4. doi: 10.1099/00222615-46-1-80.
4
Lactic acid fermentation of germinated barley fiber and proliferative function of colonic epithelial cells in loperamide-induced rats.发芽大麦纤维的乳酸发酵和洛哌丁胺诱导大鼠结肠上皮细胞的增殖功能。
J Med Food. 2010 Aug;13(4):950-60. doi: 10.1089/jmf.2009.1307.
5
The fermentation of lactulose by colonic bacteria.结肠细菌对乳果糖的发酵作用。
J Gen Microbiol. 1982 Feb;128(2):319-25. doi: 10.1099/00221287-128-2-319.
6
The association of yogurt starters with Lactobacillus casei DN 114.001 in fermented milk alters the composition and metabolism of intestinal microflora in germ-free rats and in human flora-associated rats.发酵乳中酸奶发酵剂与干酪乳杆菌DN 114.001的组合会改变无菌大鼠和人源菌群相关大鼠肠道微生物群的组成和代谢。
J Nutr. 1997 Nov;127(11):2260-6. doi: 10.1093/jn/127.11.2260.
7
Microflora and acidification properties of yogurt and yogurt-related products fermented with commercially available starter cultures.使用市售发酵剂发酵的酸奶及酸奶相关产品的微生物区系和酸化特性
Int J Food Microbiol. 1993 May;18(3):179-89. doi: 10.1016/0168-1605(93)90043-g.
8
Effects of lactulose and lactitol on colonic microflora and enzymatic activity.乳果糖和乳糖醇对结肠微生物群及酶活性的影响。
Scand J Gastroenterol Suppl. 1997;222:41-4. doi: 10.1080/00365521.1997.11720716.
9
In vitro fermentation of lactulose-derived oligosaccharides by mixed fecal microbiota.混合粪便微生物群体外发酵乳果糖衍生低聚糖。
J Agric Food Chem. 2012 Feb 29;60(8):2024-32. doi: 10.1021/jf203622d. Epub 2012 Feb 15.
10
Prospective, randomized, parallel-group trial to evaluate the effects of lactulose and polyethylene glycol-4000 on colonic flora in chronic idiopathic constipation.一项前瞻性、随机、平行组试验,以评估乳果糖和聚乙二醇4000对慢性特发性便秘患者结肠菌群的影响。
Aliment Pharmacol Ther. 2004 Apr 15;19(8):889-99. doi: 10.1111/j.1365-2036.2004.01918.x.

引用本文的文献

1
Gut microbiota in non-alcoholic fatty liver disease: Pathophysiology, diagnosis, and therapeutics.非酒精性脂肪性肝病中的肠道微生物群:病理生理学、诊断与治疗
World J Hepatol. 2025 Jun 27;17(6):106849. doi: 10.4254/wjh.v17.i6.106849.
2
The effects of candidate probiotic strains on the gut environment in dextran sulfate sodium-induced colitis mouse.候选益生菌菌株对葡聚糖硫酸钠诱导的结肠炎小鼠肠道环境的影响。
Sci Rep. 2025 Jul 1;15(1):21103. doi: 10.1038/s41598-025-03860-5.
3
Gut microbes, diet, and genetics as drivers of metabolic liver disease: a narrative review outlining implications for precision medicine.
肠道微生物、饮食和遗传作为代谢性肝病的驱动因素:一篇综述性叙述,概述了对精准医学的影响。
J Nutr Biochem. 2024 Nov;133:109704. doi: 10.1016/j.jnutbio.2024.109704. Epub 2024 Jul 17.
4
Efficacy and acceptability of different probiotic products plus laxatives for pediatric functional constipation: a network meta-analysis of randomized controlled trials.不同益生菌产品联合泻药治疗小儿功能性便秘的疗效和可接受性:随机对照试验的网络荟萃分析。
Eur J Pediatr. 2024 Aug;183(8):3531-3541. doi: 10.1007/s00431-024-05568-6. Epub 2024 May 29.
5
Milk-Fat-Globule-Membrane-Enriched Dairy Milk Compared with a Soy-Lecithin-Enriched Beverage Did Not Adversely Affect Endotoxemia or Biomarkers of Gut Barrier Function and Cardiometabolic Risk in Adults with Metabolic Syndrome: A Randomized Controlled Crossover Trial.富含乳脂肪球膜的牛奶与富含大豆卵磷脂的饮料相比,不会对代谢综合征成年人的内毒素血症或肠道屏障功能和心血管代谢风险的生物标志物产生不良影响:一项随机对照交叉试验。
Nutrients. 2023 Jul 23;15(14):3259. doi: 10.3390/nu15143259.
6
Generate Electricity through Flavin Mononucleotide-Mediated Extracellular Electron Transfer to Upregulate Epithelial Type I Collagen Expression and Thereby Promote Microbial Adhesion to Intestine.通过黄素单核苷酸介导的细胞外电子转移发电以上调上皮I型胶原蛋白表达,从而促进微生物对肠道的黏附。
Biomedicines. 2023 Feb 23;11(3):677. doi: 10.3390/biomedicines11030677.
7
TY-S01 Prevents Loperamide-Induced Constipation by Modulating Gut Microbiota and Its Metabolites in Mice.TY-S01通过调节小鼠肠道微生物群及其代谢产物预防洛哌丁胺诱导的便秘。
Front Nutr. 2022 Jun 29;9:890314. doi: 10.3389/fnut.2022.890314. eCollection 2022.
8
Prebiotics as a Tool for the Prevention and Treatment of Obesity and Diabetes: Classification and Ability to Modulate the Gut Microbiota.益生元作为预防和治疗肥胖和糖尿病的工具:分类和调节肠道微生物群的能力。
Int J Mol Sci. 2022 May 29;23(11):6097. doi: 10.3390/ijms23116097.
9
Microbiome therapeutics for hepatic encephalopathy.肠道微生态治疗肝性脑病。
J Hepatol. 2021 Dec;75(6):1452-1464. doi: 10.1016/j.jhep.2021.08.004. Epub 2021 Aug 25.
10
Multi-strain probiotics (Hexbio) containing MCP BCMC strains improved constipation and gut motility in Parkinson's disease: A randomised controlled trial.含有 MCP BCMC 菌株的多菌株益生菌(Hexbio)可改善帕金森病患者的便秘和肠道蠕动:一项随机对照试验。
PLoS One. 2020 Dec 31;15(12):e0244680. doi: 10.1371/journal.pone.0244680. eCollection 2020.